← Eichor
Study identifier: NCT04708587 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)

Condition: Chronic Kidney Diseases  ·  Sponsor: Yonsei University

PhaseNA
Planned participants900
Who can joinAll sexes, 19 Years to 84 Years
Healthy volunteersNo

About this study

The purpose of this prospective randomized clinical trial is to compare the clinical outcomes according to the duration of aspirin and clopidogrel or prasugrel with dual anti-platelet therapy after percutaneous coronary intervention in patients with advanced chronic kidney disease using a new generation drug eluting stents.

This description comes directly from the study's public registry record.

Talk to the study team

Jung-Sun Kim, MD, PhD, FESC  ·  82)-2)-2228-8457  ·  KJS1218@yuhs.ac

Always discuss trial participation with your own doctor first.

Locations (1)

Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of MedicineSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04708587